Biological and phylogenetic characteristics of yellow fever virus lineages from west africa

Journal of Virology

Volumn 87, Issue 5, 2013, Pages 2895-2907

  Stock, Nina K ^a   Laraway, Hewád ^a   Faye, Ousmane ^b   Diallo, Mawlouth ^b   Niedrig, Matthias ^a   Sall, Amadou A ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b INSTITUT PASTEUR DE DAKAR   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; INSECT CELL; LIVER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SENEGAL; SEQUENCE ANALYSIS; VERTICAL TRANSMISSION; VIROGENESIS; VIRUS GENOME; VIRUS ISOLATION; VIRUS MUTATION; VIRUS STRAIN; VIRUS TRANSMISSION; YELLOW FEVER FLAVIVIRUS;

AEDES; AFRICA, WESTERN; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; GENETIC VARIATION; GENOME, VIRAL; GENOTYPE; HEP G2 CELLS; HUMANS; INSECT VECTORS; LIVER; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; VIRAL PROTEINS; YELLOW FEVER; YELLOW FEVER VIRUS;

EID: 84874725826     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01116-12     Document Type: Article

References (42)

1. Monath TP. 2008. Treatment of yellow fever. Antiviral Res. 78:116-124.
2. Monath TP. 2001. Yellow fever: an update. Lancet Infect. Dis. 1:11-20.
3. Mutebi JP, Barrett AD. 2002. The epidemiology of yellow fever in Africa. Microbes Infect. 4:1459-1468.
4. Barrett AD, Monath TP. 2003. Epidemiology and ecology of yellow fever virus. Adv. Virus Res. 61:291-315.
5. Robertson SE, Hull BP, Tomori O, Bele O, LeDuc JW, Esteves K. 1996. Yellow fever: a decade of reemergence. JAMA 276:1157-1162.
6. Gould EA,Solomon T.2008. Pathogenic flaviviruses.Lancet 371:500-509.
7. Fontenille D, Diallo M, Mondo M, Ndiaye M, Thonnon J. 1997. First evidence of natural vertical transmission of yellow fever virus in Aedes aegypti, its epidemic vector. Trans. R. Soc. Trop. Med. Hyg. 91:533-535.
8. Barrett AD, Higgs S. 2007. Yellow fever: a disease that has yet to be conquered. Annu. Rev. Entomol. 52:209-229.
9. Gould EA, de Lamballerie X, Zanotto PM, Holmes EC. 2003. Origins, evolution, and vector/host coadaptations within the genus Flavivirus. Adv. Virus Res. 59:277-314.
10. de Souza RP, Foster PG, Sallum MA, Coimbra TL, Maeda AY, Silveira VR, Moreno ES, da Silva FG, Rocco IM, Ferreira IB, Suzuki A, Oshiro FM, Petrella SM, Pereira LE, Katz G, Tengan CH, Siciliano MM, Dos Santos CL. 2010. Detection of a new yellow fever virus lineage within the South American genotype I in Brazil. J. Med. Virol. 82:175-185.
11. Mutebi JP Wang H, Li L, Bryant JE, Barrett AD. 2001. Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa. J. Virol. 75:6999-7008.
12. von Lindern JJ, Aroner S, Barrett ND, Wicker JA, Davis CT, Barrett AD. 2006. Genome analysis and phylogenetic relationships between east, central and west African isolates of Yellow fever virus. J. Gen. Virol. 87: 895-907.
13. Chang GJ, Cropp BC, Kinney RM, Trent DW, Gubler DJ. 1995. Nucleotide sequence variation of the envelope protein gene identifies two distinct genotypes of yellow fever virus. J. Virol. 69:5773-5780.
14. Lepiniec L, Dalgarno L, Huong VT, Monath TP, Digoutte JP, Deubel V. 1994. Geographic distribution and evolution of yellow fever viruses based on direct sequencing of genomic cDNA fragments. J. Gen. Virol. 75(Pt 2):417-423
15. Sall AA, Faye O, Diallo M, Firth C, Kitchen A, Holmes EC. 2010. Yellow fever virus exhibits slower evolutionary dynamics than dengue virus. J. Virol. 84:765-772.
16. Wang E, Weaver SC, Shope RE, Tesh RB, Watts DM, Barrett AD. 1996. Genetic variation in yellow fever virus: duplication in the 3= noncoding region of strains from Africa. Virology 225:274-281.
17. Deubel V, Pailliez JP, Cornet M, Schlesinger JJ, Diop M, Diop A, Digoutte JP, Girard M. 1985. Homogeneity among Senegalese strains of yellow fever virus. Am. J. Trop. Med. Hyg. 34:976-983.
18. Ferguson M, Heath A. 2004. Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine. Biologicals 32:195-205.
19. Gelderblom HR, Kocks C, L'Age-Stehr J, Reupke H. 1985. Comparative immunoelectron microscopy with monoclonal antibodies on yellow fever virus-infected cells: pre-embedding labelling versus immunocryoultramicrotomy. J. Virol. Methods 10:225-239.
20. Weidmann M, Faye O, Kranaster R, Marx A, Nunes MR, Vasconcelos PF, Hufert FT, Sall AA. 2010. Improved LNA probe-based assay for the detection of African and South American yellow fever virus strains. J. Clin. Virol. 48
21. Bae H-G. 2006. Analyse der Immunantwort nach Infektion mit Gelbfieberviren. Freie Universität Berlin, Berlin, Germany.
22. Stock NK, Boschetti N, Herzog C, Appelhans MS, Niedrig M. 2012. The phylogeny of yellow fever virus 17D vaccines. Vaccine 30:989-994.
23. Ronquist F, Huelsenbeck JP. 2003. MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19:1572-1574.
24. Gouy M, Guindon S, Gascuel O. 2010. SeaView version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol. Biol. Evol. 27:221-224.
25. Pisano MR, Nicoli J, Tolou H. 1997. Homogeneity of yellow fever virus strains isolated during an epidemic and a post-epidemic period in West Africa. Virus Genes 14:225-234.
26. Frierson JG. 2010. The yellow fever vaccine: a history. Yale J. Biol. Med. 83:77-85.
27. Mukhopadhyay S, Kuhn RJ, Rossmann MG. 2005. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 3:13-22.
28. Miller S, Kastner S, Krijnse-Locker J, Buhler S, Bartenschlager R. 2007. The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner. J. Biol. Chem. 282:8873-8882.
29. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A. 2003. Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. U. S. A. 100:14333-14338.
30. Bollati M, Alvarez K, Assenberg R, Baronti C, Canard B, Cook S, Coutard B, Decroly E, de Lamballerie X, Gould EA, Grard G, Grimes JM, Hilgenfeld R, Jansson AM, Malet H, Mancini EJ, Mastrangelo E, Mattevi A, Milani M, Moureau G, Neyts J, Owens RJ, Ren J, Selisko B, Speroni S, Steuber H, Stuart DI, Unge T, Bolognesi M. 2010. Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res. 87:125-148.
31. Malet H, Masse N, Selisko B, Romette JL, Alvarez K, Guillemot JC, Tolou H, Yap TL, Vasudevan S, Lescar J, Canard B. 2008. The flavivirus polymerase as a target for drug discovery. Antiviral Res. 80:23-35.
32. Mutebi JP, Rijnbrand RC, Wang H, Ryman KD, Wang E, Fulop LD, Titball R, Barrett AD. 2004. Genetic relationships and evolution of genotypes of yellow fever virus and other members of the yellow fever virus group within the Flavivirus genus based on the 3= noncoding region. J. Virol. 78:9652-9665.
33. Proutski V, Gaunt MW, Gould EA, Holmes EC. 1997. Secondary structure of the 3=-untranslated region of yellow fever virus: implications for virulence, attenuation and vaccine development. J. Gen. Virol. 78(Pt 7):1543-1549.
34. Proutski V, Gould EA, Holmes EC. 1997. Secondary structure of the 3= untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res. 25:1194-1202.
35. Gritsun TS, Gould EA. 2006. Direct repeats in the 3= untranslated regions of mosquito-borne flaviviruses: possible implications for virus transmission. J. Gen. Virol. 87:3297-3305.
36. Bryant JE, Vasconcelos PF, Rijnbrand RC, Mutebi JP, Higgs S, Barrett AD. 2005. Size heterogeneity in the 3= noncoding region of South American isolates of yellow fever virus. J. Virol. 79:3807-3821.
37. Bae HG, Drosten C, Emmerich P, Colebunders R, Hantson P, Pest S, Parent M, Schmitz H, Warnat MA, Niedrig M. 2005. Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium. J. Clin. Virol. 33:274-280.
38. Lefeuvre A, Contamin H, Decelle T, Fournier C, Lang J, Deubel V, Marianneau P. 2006. Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection. Microbes Infect. 8:1530-1538.
39. Marianneau P, Megret F, Olivier R, Morens DM, Deubel V. 1996. Dengue 1 virus binding to human hepatoma HepG2 and simian Vero cell surfaces differs. J. Gen. Virol. 77(Pt 10):2547-2554.
40. Marianneau P, Steffan AM, Royer C, Drouet MT, Kirn A, Deubel V. 1998. Differing infection patterns of dengue and yellow fever viruses in a human hepatoma cell line. J. Infect. Dis. 178:1270-1278.
41. Thepparit C, Phoolcharoen W, Suksanpaisan L, Smith DR. 2004. Internalization and propagation of the dengue virus in human hepatoma (HepG2) cells. Intervirology 47:78-86.
42. Cooper LA, Scott TW. 2001. Differential evolution of eastern equine encephalitis virus populations in response to host cell type. Genetics 157:1403-1412. Characterization of YFV Lineages from West Africa March